With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Developing Targeted Immunotherapy Against Pediatric Acute Myeloid Leukemia||Fred Hutchinson Cancer Research Center / Melinda Biernacki, MD||Young Investigator Grants||2016||Washington|
|Restoring RUNX1 Levels in FPD/AML||University of Washington, Seattle / Marshall Horwitz, MD/PhD||Familial RUNX1 Research Grants||2016||Washington|
|Engineering A Graft Versus Leukemia Effect into Cord Blood Transplant for Acute Lymphoblastic Leukemia||Fred Hutchinson Cancer Research Center / Rebecca Gardner||Young Investigator Grants||2011||Washington|
|Establishing the Function of Novel MicroRNAs Associated with Resistance and Relapse in Pediatric AML||Fred Hutchinson Cancer Research Center / Vivian Oehler, MD & Soheil Meshinchi, MD/PhD||Innovation Grants||2017||Washington|
|Prognostic and Therapeutic Significance of Stem Cell Heterogeneity in AML||Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD||'A' Award Grants||2012||Washington|
|Genomic Alterations in ETV6 Predict Outcome in Pediatric AML||Fred Hutchinson Cancer Research Center / Heather Helton, MD||Young Investigator Grants||2013||Washington|
|Accelerating Access to Cellular Therapies for the Treatment of Childhood Malignancies||Seattle Children's Hospital and Regional Medical Center / Julie Park, MD||Phase I/II Infrastructure Grants||2013||Washington|
|Optimizing Bispecific Antibody Therapy for Acute Leukemias||Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD & James Olson, MD, PhD||Innovation Grants||2015||Washington|
|Use sophisticated approaches to optimize the effectiveness of current chemotherapy agents, and to develop novel chemotherapy agents||Seattle Children's Hospital and Regional Medical Center / Julie Park, MD||Phase I/II Infrastructure Grants||2006||Washington|
|Characterization of Chromatin Landscapes to Identify Therapeutic Vulnerabilities in Diffuse Midline Gliomas.||Fred Hutchinson Cancer Research Center / Jay Sarthy, MD/PhD||Young Investigator Grants||2019||Washington|